About CTRL Therapeutics USA
CTRL Therapeutics USA is a private company based in Glencoe, Illinois, incorporated in 2022 in Delaware. It has reported $16,638,892 raised in two offerings on Form D since October 2022. Its chief executive is Derrell Porter.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Sep 19, 2024 | Sep 27, 2024 | $9,135,991of $9.9M target | 5 | $1.8M | EquityRule 506(b) | Form D ↗ |
| Oct 12, 2022 | Oct 27, 2022 | $7,502,901of $10.6M target | 7 | $1.0M | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $16,638,892 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on CTRL Therapeutics USA's Form D filed Sep 27, 2024.
DP
Derrell Porter
Chief Executive Officer and director
CT
Collin Todd
Director
DN
David O'Neill
Director
SK
Shana Kelley
Executive officer and director
Earlier filings also listed Michael Kalos (director, last listed Oct 2022) and Elena Viboch (director, last listed Oct 2022).